Spanish biopharmaceutical company PharmaMar has selected Medidata Solutions' Medidata Clinical Cloud platform to accelerate clinical trials for marine-based oncology drugs. A member of the Zeltia Group and a developer of antitumor drugs ...
Immunobiology (ImmBio), a UK-based biopharmaceutical company, has bagged £0.2m in funding from the UK government-backed Biomedical Catalyst (BBC) for the pre-clinical development of pneumococcal vaccine PnuBioVax. The pharma company ...
Merck, referred to as MSD outside the US and Canada, and Luminex have signed a deal to develop a companion diagnostic device to support patient selection for the clinical development program of investigational drug MK-8931 to treat ...
Tags: companion diagnostic device, drug, Merck
Chimerix, a US-based company which discovers, develops and commercializes oral antiviral therapeutics, has won the US Food and Drug Administration (FDA) fast track designation for CMX001 for the prevention of cytomegalovirus (CMV) ...
Tags: Chimerix, oral antiviral therapeutics, FDA, CMX001
Labceutics has signed a agreement with Asuragen to conduct an international multi-center quality assurance study on the standardization of BCR-ABL1 quantitative measurements on the International Scale (IS). Participating laboratories ...
Tags: Labceutics, Asuragen, Conduct Pan European Study, CML
Takeda Pharmaceutical Company has submitted marketing authorisation application (MAA) seeking approval from the European Medicines Agency (EMA) for its investigational, gut-selective humanized monoclonal antibody for the treatment of adults ...
Tags: Takeda, IBD Disease Drug, MAA, EMA
US-based biopharmaceutical company Spring Bank Pharmaceuticals has closed a $10.5m Series A financing round from Brock Securities with Gilford Securities as a participator. The firm is planning to invest the fund in its Phase I clinical ...
Imprimis Pharmaceuticals has announced the completion of clinical trials of Impracor, a topical analgesic cream, which delivers a therapeutic dose of the pain-relieving, anti-inflammatory drug ketoprofen. The study, which was conducted by ...
The US Patent and Trademark Office (USPTO) has granted notice of allowance (NOA) to Collegium Pharmaceutical's patent application NO.12/823,628 covering a tamper-resistant, extended-release opioid product. The patent entitled, ...
Tags: USPTO, NOA, Collegium Opioid Product
Domain Therapeutics SA announced today that Domain Therapeutics grants Prexton Therapeutics an exclusive option to license and develop metabotropic glutamate receptor 4 (mGluR4) Positive Allosteric Modulator (PAM) drugs targeting ...
Tags: Domain Therapeutics SA, chemical, drugs
Pergamum and Cadila Pharmaceuticals have entered into a strategic collaboration for the development of a new therapeutic peptide targeting infections using a distinctive mechanism. The collaboration will focus on preclinical and clinical ...
Tags: Pergamum, Cadila Pharmaceuticals, strategic collaboration
UK-based pharmaceutical company Bristol-Myers Squibb and AstraZeneca have announced that the National Institute for Health and Clinical Excellence (NICE) in the UK has issued an Appraisal Consultation Document (ACD) for its first-in-class, ...
Tags: pharmaceutical company, Bristol-Myers Squibb, AstraZeneca, NICE
Pfizer's bosutinib has received positive opinion for the conditional marketing authorization from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP). The bosutinib positive CHMP opinion is concerned with ...
Aileron Therapeutics has secured the second tranche in its series D financing, meaning the overall total has now reached $42 million (pound 26 million). This payment followed the successful progression of the company's ALRN-5281 lead ...
Evotec has reached a milestone in drug discovery collaboration with Ono Pharmaceutical with the progression of a compound into pre-clinical development. The advancement of the compound into the pre-clinical development triggers an agreed ...
Tags: Evotec, drug, Ono Pharmaceutical